Evidence map›Paper›PMID 33325834›Full record

ArticleJMIR medical informatics2020

Cystic Fibrosis Point of Personalized Detection (CFPOPD): An Interactive Web Application.

Christopher Wolfe, Teresa Pestian, Emrah Gecili, Weiji Su, Ruth H Keogh, John P Pestian, Michael Seid, Peter J Diggle, Assem Ziady, John Paul Clancy and 3 more

Open access · goldAbstract read
In one paragraph

Article in JMIR medical informatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Christopher Wolfe *Division of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0002-5882-1149
Teresa Pestian *Division of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0003-3163-691X
Emrah GeciliDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0001-5221-4922
Weiji SuDivision of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0002-5426-9764
Ruth H KeoghDepartment of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0001-6504-3253
John P PestianDepartment of Pediatrics, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0001-5998-249X
Michael SeidDepartment of Pediatrics, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0001-9773-9263
Peter J DiggleCentre for Health Informatics, Computing, and Statistics, Lancaster Medical School, Lancaster University, Lancaster, United Kingdom.ORCID https://orcid.org/0000-0003-3521-5020
Assem ZiadyDepartment of Pediatrics, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0001-8959-7218
John Paul ClancyDepartment of Pediatrics, University of Cincinnati, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0003-2867-9740
Daniel H GrossoehmeHaslinger Family Pediatric Palliative Care Center, Akron Children's Hospital, Akron, OH, United States.ORCID https://orcid.org/0000-0002-5654-0693
Rhonda D Szczesniak *Division of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0003-0705-715X
Cole Brokamp *Division of Biostatistics & Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.ORCID https://orcid.org/0000-0002-0289-3151
Cincinnati Children's Hospital Medical Center · USAkron Children's Hospital · USHealth Data Research UK · GBLondon School of Hygiene & Tropical Medicine · GB

Funding

R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosisR01HL141286 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SZCZESNIAK, RHONDA · 2019 to 2023
$2.3M
Predictive Molecular Markers of Lung Function DeclineR01HL142210 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI ZIADY, ASSEM G · 2019 to 2022
$1.7M
Commercial Translation of Biomarker-based Platform for Personalized Forecasting of Rapid Lung Function DeclineR61HL154105 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SZCZESNIAK, RHONDA, ZIADY, ASSEM G · 2020 to 2021
$789k
Preventing rapid decline in CF: statistical research career commitmentK25HL125954 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SZCZESNIAK, RHONDA · 2015 to 2019
$762k
Medical Research Council MR/S017968/1NHLBI NIH HHS K25 HL125954NHLBI NIH HHS R01 HL141286NHLBI NIH HHS R01 HL142210NHLBI NIH HHS R61 HL154105
6 · The paper itself

Abstract

backgroundDespite steady gains in life expectancy, individuals with cystic fibrosis (CF) lung disease still experience rapid pulmonary decline throughout their clinical course, which can ultimately end in respiratory failure. Point-of-care tools for accurate and timely information regarding the risk of rapid decline is essential for clinical decision support.

objectiveThis study aims to translate a novel algorithm for earlier, more accurate prediction of rapid lung function decline in patients with CF into an interactive web-based application that can be integrated within electronic health record systems, via collaborative development with clinicians.

methodsLongitudinal clinical history, lung function measurements, and time-invariant characteristics were obtained for 30,879 patients with CF who were followed in the US Cystic Fibrosis Foundation Patient Registry (2003-2015). We iteratively developed the application using the R Shiny framework and by conducting a qualitative study with care provider focus groups (N=17).

resultsA clinical conceptual model and 4 themes were identified through coded feedback from application users: (1) ambiguity in rapid decline, (2) clinical utility, (3) clinical significance, and (4) specific suggested revisions. These themes were used to revise our application to the currently released version, available online for exploration. This study has advanced the application's potential prognostic utility for monitoring individuals with CF lung disease. Further application development will incorporate additional clinical characteristics requested by the users and also a more modular layout that can be useful for care provider and family interactions.

conclusionsOur framework for creating an interactive and visual analytics platform enables generalized development of applications to synthesize, model, and translate electronic health data, thereby enhancing clinical decision support and improving care and health outcomes for chronic diseases and disorders. A prospective implementation study is necessary to evaluate this tool's effectiveness regarding increased communication, enhanced shared decision-making, and improved clinical outcomes for patients with CF.

Indexed as

application programming interfacechronic diseaseclinical decision rulesclinical decision supportmedical monitoring

Identifiers

PMID33325834
PMCPMC7773511
OpenAlexW3112799330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.